HAIR REGROWTH TREATMENT 2 %
MINOXIDIL : 2 % · DIN 02460181 · APOTEX INC
Health Canada status: APPROVED
What is HAIR REGROWTH TREATMENT?
HAIR REGROWTH TREATMENT 2 % contains MINOXIDIL : 2 %. It is listed in the Health Canada Drug Product Database under DIN 02460181, held by APOTEX INC, supplied as SOLUTION for TOPICAL administration. Health Canada currently lists it as approved, status dated 23-Dec-2016. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02460181 |
|---|---|
| Brand name | HAIR REGROWTH TREATMENT |
| Generic / active ingredient | MINOXIDIL : 2 % |
| Manufacturer | APOTEX INC |
| Strength | 2 % |
| Dosage form | SOLUTION |
| Route of administration | TOPICAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | D11AX01 MINOXIDIL, TOPICAL |
| AHFS class | 12:20.20.24 |
| Biosimilar | No |
| Health Canada status | APPROVED |
| Status date | 23-Dec-2016 |
| Original market date | 2017-02-27 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code D11AX01 MINOXIDIL, TOPICAL. 7 of 16 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| HAIR REGROWTH FORMULA | 20 MG | SOLUTION | VITA HEALTH PRODUCTS INC | MARKETED | DIN 02356597 |
| MEN'S GLN-MINOXIDIL | 5 % | AEROSOL, FOAM | GLENMARK PHARMACEUTICALS CANADA INC. | MARKETED | DIN 02553465 |
| MEN'S MINOXIDIL FOAM | 5 % | AEROSOL, FOAM | TARO PHARMACEUTICALS INC | MARKETED | DIN 02551446 |
| MEN'S ROGAINE | 20 MG | SOLUTION | JOHNSON & JOHNSON INC | MARKETED | DIN 00708925 |
| MEN'S ROGAINE FOAM 5% | 5 % | AEROSOL, FOAM | JOHNSON & JOHNSON INC | MARKETED | DIN 02368684 |
| WOMEN'S MINOXIDIL FOAM | 5 % | AEROSOL, FOAM | TARO PHARMACEUTICALS INC | MARKETED | DIN 02551659 |
| WOMEN'S ROGAINE FOAM 5% | 5 % | AEROSOL, FOAM | JOHNSON & JOHNSON INC | MARKETED | DIN 02424703 |
| APO-GAIN LIQ 20MG/ML | 20 MG | SOLUTION | APOTEX INC | DORMANT | DIN 00885754 |
| GEN-MINOXIDIL LIQ 2% | 2 % | LIQUID | GENPHARM ULC | CANCELLED POST MARKET | DIN 02065800 |
| HAIR REGROWTH TREATMENT | 2 % | SOLUTION | VITA HEALTH PRODUCTS INC | CANCELLED POST MARKET | DIN 02242377 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.